The Promise of Genome Editing for Modeling Psychiatric Disorders

Stephanie Pb Caligiuri; Paul J. Kenny

doi:10.1038/npp.2017.197

The Promise of Genome Editing for Modeling Psychiatric Disorders

Stephanie Pb Caligiuri, Paul J. Kenny

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	223-224
Number of pages	2
Journal	Neuropsychopharmacology
Volume	43
Issue number	1
DOIs	https://doi.org/10.1038/npp.2017.197
State	Published - 1 Jan 2018

Access to Document

10.1038/npp.2017.197

Cite this

@article{e1182fb8a7a840239042bbbfbd93d78a,

title = "The Promise of Genome Editing for Modeling Psychiatric Disorders",

author = "Caligiuri, {Stephanie Pb} and Kenny, {Paul J.}",

note = "Funding Information: This work was supported by grants DA025983, AA024292, MH112168, NS083614 from the NIH (PJK), a NARSAD-distinguished investigator grant (PJK), and a post-doctoral fel lowship from the Canadian Institutes of Health Research (SC). PJK is a shareholder in Eolas Therapeutics and is a consultant for Florida House Experience. The remaining author declares no conflict of interest.",

year = "2018",

month = jan,

day = "1",

doi = "10.1038/npp.2017.197",

language = "English",

volume = "43",

pages = "223--224",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - The Promise of Genome Editing for Modeling Psychiatric Disorders

AU - Caligiuri, Stephanie Pb

AU - Kenny, Paul J.

N1 - Funding Information: This work was supported by grants DA025983, AA024292, MH112168, NS083614 from the NIH (PJK), a NARSAD-distinguished investigator grant (PJK), and a post-doctoral fel lowship from the Canadian Institutes of Health Research (SC). PJK is a shareholder in Eolas Therapeutics and is a consultant for Florida House Experience. The remaining author declares no conflict of interest.

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85036635950&partnerID=8YFLogxK

U2 - 10.1038/npp.2017.197

DO - 10.1038/npp.2017.197

M3 - Article

C2 - 29192655

AN - SCOPUS:85036635950

SN - 0893-133X

VL - 43

SP - 223

EP - 224

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

IS - 1

ER -